NASDAQ:GBT
Global Blood Therapeutics, Inc.
- Stock
Last Close
68.48
04/10 20:00
Volume Today
3.28M
Avg: -
PE Ratio
−27.41
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -20.81M - | -46.36M 122.81% | -82.47M 77.89% | -117.02M 41.90% | -174.19M 48.85% | -266.77M 53.14% | -247.55M 7.20% | -303.09M 22.43% | |
depreciation and amortization | 666K - | 873K 31.08% | 1.24M 41.47% | 1.66M 34.25% | 4.61M 177.86% | 9.93M 115.58% | 10.82M 8.97% | 8.62M 20.39% | |
deferred income tax | |||||||||
stock based compensation | 350K - | 3.22M 820.86% | 9.23M 186.53% | 13.68M 48.15% | 30.08M 119.85% | 45.65M 51.77% | 71.48M 56.57% | 78.67M 10.06% | |
change in working capital | -627K - | 6.85M 1,192.34% | 4.28M 37.58% | 7.96M 86.15% | 4.75M 40.35% | 27.08M 470.49% | -47.27M 274.54% | -42.44M 10.22% | |
accounts receivables | -2.64M - | -14.86M 463.63% | -11.30M 23.97% | ||||||
inventory | -1.28M - | -36.78M 2,780.11% | -16.15M 56.09% | ||||||
accounts payables | -304K - | 2.71M 989.80% | 1.07M 60.59% | 2.77M 159.94% | -1.28M 146.37% | 4.50M 450.12% | 8.37M 86.13% | -3.72M 144.45% | |
other working capital | -323K - | 4.14M 1,382.97% | 3.21M 22.56% | 5.19M 61.64% | 6.03M 16.29% | 26.50M 339.26% | -4.00M 115.09% | -11.27M 181.72% | |
other non cash items | 297K - | 4.53M 1,423.57% | 704K - | -616K 187.50% | -10.31M 1,574.51% | 658K 106.38% | 1.43M 117.02% | ||
net cash provided by operating activities | -20.12M - | -30.89M 53.52% | -67.72M 119.24% | -93.02M 37.36% | -135.38M 45.53% | -194.42M 43.61% | -211.86M 8.97% | -256.81M 21.22% | |
investments in property plant and equipment | -323K - | -993K 207.43% | -1.35M 36.15% | -3.10M 129.36% | -4.82M 55.56% | -3.46M 28.28% | -8.75M 153.01% | -3.23M 63.07% | |
acquisitions net | |||||||||
purchases of investments | -105.50M - | -127.72M 21.07% | -361.40M 182.96% | -434.92M 20.34% | -57.94M 86.68% | -50.35M 13.09% | |||
sales maturities of investments | 96.01M - | 182.00M 89.56% | 361.47M 98.61% | 384.00M 6.23% | 65.70M 82.89% | ||||
other investing activites | -60K - | -1.09M - | 75K 106.88% | 45K 40% | |||||
net cash used for investing activites | -383K - | -993K 159.27% | -106.85M 10,660.52% | -35.91M 66.40% | -184.16M 412.89% | -76.86M 58.26% | 317.31M 512.84% | 12.11M 96.18% | |
debt repayment | |||||||||
common stock issued | 128.34M - | 117.00M 8.84% | 231.96M 98.26% | 396.50M 70.94% | 219.44M 44.66% | 46.14M - | |||
common stock repurchased | -67K - | -90K 34.33% | -421K 367.78% | -12K 97.15% | |||||
dividends paid | |||||||||
other financing activites | 69.30M - | 45K 99.94% | 1.24M 2,655.56% | 3.65M 194.68% | 1.42M 61.22% | 78.72M 5,455.05% | 87.12M 10.68% | 388.19M 345.58% | |
net cash used provided by financing activities | 69.30M - | 128.32M 85.17% | 118.14M 7.93% | 235.19M 99.07% | 397.91M 69.19% | 298.16M 25.07% | 87.12M 70.78% | 434.33M 398.55% | |
effect of forex changes on cash | 319K - | ||||||||
net change in cash | 48.79M - | 96.43M 97.65% | -56.43M 158.52% | 106.26M 288.30% | 78.37M 26.24% | 26.88M 65.70% | 192.57M 616.41% | 189.95M 1.36% | |
cash at beginning of period | 3.28M - | 52.07M 1,488.44% | 148.50M 185.20% | 92.07M 38.00% | 199.38M 116.55% | 277.75M 39.31% | 304.63M 9.68% | 497.20M 63.21% | |
cash at end of period | 52.07M - | 148.50M 185.20% | 92.07M 38.00% | 198.33M 115.41% | 277.75M 40.04% | 304.63M 9.68% | 497.20M 63.21% | 687.15M 38.20% | |
operating cash flow | -20.12M - | -30.89M 53.52% | -67.72M 119.24% | -93.02M 37.36% | -135.38M 45.53% | -194.42M 43.61% | -211.86M 8.97% | -256.81M 21.22% | |
capital expenditure | -323K - | -993K 207.43% | -1.35M 36.15% | -3.10M 129.36% | -4.82M 55.56% | -3.46M 28.28% | -8.75M 153.01% | -3.23M 63.07% | |
free cash flow | -20.44M - | -31.88M 55.95% | -69.08M 116.65% | -96.12M 39.16% | -140.20M 45.85% | -197.88M 41.14% | -220.62M 11.49% | -260.05M 17.87% |
All numbers in USD (except ratios and percentages)